Magnesium sulfate (medical use) ionic strength prevents some of the temporary skin wrinkling (partial maceration) which is caused by prolonged immersion of extremities in pure water. Magnesium and sulfate ions are naturally present in some mineral waters. The claimed health benefits of Epsom Salt baths have not been proven. A magnesium sulphate paste is also available which is claimed to be useful for small boils or localised infections. The standard British Pharmacopoeia composition is dried Magnesium Sulfate 47.76 % w/w, Phenol 0.49 % w/w. and glycerol (E422). Magnesium sulfate has been used as an experimental treatment of Irukandji syndrome caused by envenomation by certain
Magnesium hydroxide in 1872 for a suspension of magnesium hydroxide formulated at about 8%w/v. It was sold under the brand name "Phillips' Milk of Magnesia" for medicinal usage. Although the name may at some point have been owned by GlaxoSmithKline, USPTO registrations show "Milk of Magnesia" and "Phillips' Milk of Magnesia" have both been assigned to Bayer since 1995. In the UK, the non-brand (generic) name of "Milk of Magnesia" and "Phillips' Milk of Magnesia" is "Cream of Magnesia" (Magnesium Hydroxide Mixture, BP). It is added directly to human food, and is affirmed as generally recognized as safe by the FDA. It